An FDA advisory panel is finally set to review Avandia today, after some research found it to increase the risk of causing a heart attack. There's a range of things that could happen here, though it's thought to be a touch premature to withdraw the drug completely. The agency doesn't have to follow the panel's advice of course, but it usually does. For all our past Avandia coverage see here.
Have you registered with us yet?
Register now to enjoy more articles and free email bulletins